These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
291 related items for PubMed ID: 19118894
1. Inhibition of titanium particle-induced osteoclastogenesis through inactivation of NFATc1 by VIVIT peptide. Liu F, Zhu Z, Mao Y, Liu M, Tang T, Qiu S. Biomaterials; 2009 Mar; 30(9):1756-62. PubMed ID: 19118894 [Abstract] [Full Text] [Related]
6. The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Koreny T, Tunyogi-Csapó M, Gál I, Vermes C, Jacobs JJ, Glant TT. Arthritis Rheum; 2006 Oct; 54(10):3221-32. PubMed ID: 17009257 [Abstract] [Full Text] [Related]
7. Osteopontin deficiency impairs wear debris-induced osteolysis via regulation of cytokine secretion from murine macrophages. Shimizu S, Okuda N, Kato N, Rittling SR, Okawa A, Shinomiya K, Muneta T, Denhardt DT, Noda M, Tsuji K, Asou Y. Arthritis Rheum; 2010 May; 62(5):1329-37. PubMed ID: 20155835 [Abstract] [Full Text] [Related]
8. Inhibition of osteoclast differentiation and bone resorption by sauchinone. Han KY, Yang D, Chang EJ, Lee Y, Huang H, Sung SH, Lee ZH, Kim YC, Kim HH. Biochem Pharmacol; 2007 Sep 15; 74(6):911-23. PubMed ID: 17662251 [Abstract] [Full Text] [Related]
9. Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles. Carmody EE, Schwarz EM, Puzas JE, Rosier RN, O'Keefe RJ. Arthritis Rheum; 2002 May 15; 46(5):1298-308. PubMed ID: 12115237 [Abstract] [Full Text] [Related]
10. Aminocoumarins inhibit osteoclast differentiation and bone resorption via downregulation of nuclear factor of activated T cells c1. Zheng T, Noh AL, Park H, Yim M. Biochem Pharmacol; 2013 Feb 01; 85(3):417-25. PubMed ID: 23123663 [Abstract] [Full Text] [Related]
11. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor. Kubota T, Hoshino M, Aoki K, Ohya K, Komano Y, Nanki T, Miyasaka N, Umezawa K. Arthritis Res Ther; 2007 Feb 01; 9(5):R97. PubMed ID: 17892600 [Abstract] [Full Text] [Related]
12. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling. Yang J, Park OJ, Lee YJ, Jung HM, Woo KM, Choi Y. Eur J Immunol; 2008 Jun 01; 38(6):1598-609. PubMed ID: 18421790 [Abstract] [Full Text] [Related]
13. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. Schwarz EM, Lu AP, Goater JJ, Benz EB, Kollias G, Rosier RN, Puzas JE, O'Keefe RJ. J Orthop Res; 2000 May 01; 18(3):472-80. PubMed ID: 10937636 [Abstract] [Full Text] [Related]
14. IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions. Kohara H, Kitaura H, Fujimura Y, Yoshimatsu M, Morita Y, Eguchi T, Masuyama R, Yoshida N. Immunol Lett; 2011 Jun 30; 137(1-2):53-61. PubMed ID: 21338623 [Abstract] [Full Text] [Related]
17. Bavachalcone inhibits osteoclast differentiation through suppression of NFATc1 induction by RANKL. Park CK, Lee Y, Chang EJ, Lee MH, Yoon JH, Ryu JH, Kim HH. Biochem Pharmacol; 2008 Jun 01; 75(11):2175-82. PubMed ID: 18433733 [Abstract] [Full Text] [Related]